As Omicron cases are rapidly spreading all across the world, a latest study has revealed that a three-shot course of the Pfizer-BioNTech Covid vaccine offers protection against the new variant, Omicron.

Israeli study finds Pfizer booster to be effective against Omicron variant

According to an investigation by the UK-based Channel 4, drug major Pfizer allegedly paid experts to lie about Covid vaccine made by its rival AstraZeneca along with Oxford University.

Investigative report claims Pfizer paid money to spread lies about AstraZeneca Covid jab

The head of US pharma giant, Pfizer, has said that yearly Covid vaccination might be necessary to maintain a “very high level of protection”. Dr Albert Bourla, chief executive at the company which delivered the world's first Covid vaccine a year ago, said the countries may have to rely on jabs for many years to come to counter new variants and waning immunity.

Yearly Covid vaccinations necessary to counter new variants, waning immunity: Pfizer boss

As concerns grow about the impact of the new Omicron variant, Pfizer announced on Tuesday it was seeking US authorization for booster shots for adolescents aged 16 and 17.

Pfizer seeks US FDA approval for Covid boosters for teens aged 16-17

Pfizer's covid-19 vaccine seems to be promising for youngsters. New trial data shows that the jab is providing long-term efficacy in adolescents, here's the report.

Covid Vaccine News: Pfizer vaccine looms promising for youngsters

In what has been termed as a "a major milestone" by Health Canada, the country has now authorised the use of the Pfizer-BioNTech vaccine for children between 5 and 11.

'A major milestone': Canada approves Pfizer Covid-19 vaccine for kids aged 5-11

The United States authorised the Pfizer and Moderna Covid vaccine boosters to all people aged 18 and older on Friday, as the world's hardest-hit country enters a new winter wave of the pandemic.

COVID-19: US authorises boosters of the Pfizer/BioNTech and Moderna vaccines for all adults

Pharma giant Pfizer said on Thursday that it had struck a deal to sell 10 million Covid-19 treatment courses to US government for USD 5.3 billion. It said that approval of the agreement was pending from regulators.

Pfizer strikes USD 5.3 billion deal to sell 10 million COVID treatments in US

Did Pfizer, BioNTech & Moderna prioritise their Wuhan virus vaccine supplies to rich countries to make billions in profits? A report has claimed that the companies are making $1000 per second in profits from their shots. Palki Sharma tells you more.

Gravitas: 3 companies. 2 Covid-19 vaccines. $34 Billion in profits

U.S. pharma giant Pfizer has signed a license-sharing deal one that will allow its experimental COVID-19 pill to be manufactured in 95 countries. This means that the pill will be easily available to more than half of the globe.

U.S. pharma giant Pfizer's COVID-19 pill to be manufactured in 95 countries

South Korea is facing a rapid surge in coronavirus cases despite achieving a high rate of inoculation. The country is mulling to reduce the gap for booster doses from six to four months.

South Korea battling rapid surge in COVID-19 cases despite nearly 90% vaccination rate

Pharma giant Pfizer and UN-backed international public health group Medicines Patent Pool (MPP) on Tuesday struck a licensing agreement over Pfizer's COVID-19 pill.

Pfizer to allow other companies to manufacture Covid pill in 95 countries

Taiwan’s health minister Chen Shih-chung has said that they are suspending second doses of the Pfizer-BioNTech (BNT) Covid vaccine to children in the 12-17 age group amid concerns that it may increase the risk of myocarditis.

Taiwan suspends 2nd dose Pfizer Covid vaccine for 12-17 olds over heart inflammation

WHO approved Covaxin earlier, but Pfizer's vaccine trial questioned over data integrity, regulatory oversight

Was Pfizer's vaccine trial compromised?

Was Pfizer's Wuhan Virus vaccine trial compromised? A whistleblower who worked for the company hired to run the trial spotted several lapses. She was allegedly fired after she sent a complaint to US FDA. Palki Sharma brings you a report.

Gravitas: Was Pfizer's Covid-19 vaccine trial "compromised"?

Pfizer has claimed that their experimental pill against the deadly coronavirus has the capacity to reduce the risk of hospitalisation and deaths in high-risk patients.

Pfizer's experimental Covid pill reduces hospitalisations and deaths, company claims

Pfizer's kid-size COVID-19 injection received final approval from US health regulators on Tuesday, paving the way for a substantial extension of the country's vaccination campaign to include children as young as 5.

COVID-19 vaccine for children: US gives final nod to Pfizer jabs for 5-11 age group

The United States has approved Pfizer-BioNTech’s COVID-19 vaccine for children from the ages of 5 to 11, it is a major milestone in country's fight against the pandemic.

United States: CDC approves Pfizer-BioNTech’s COVID-19 vaccine for children

The US Centers for Disease Control and Prevention (CDC) has officially approved Pfizer-BioNTech’s COVID-19 vaccine for children from the ages of 5 to 11. This means that up to 28 million children in the age group will be eligible for the shots.

US CDC approves Pfizer's COVID-19 vaccine for children ages 5 to 11

The United States on Monday provided as many as 100,620 doses of Pfizer COVID-19 vaccines to Nepal through COVAX. This adds up to the 1.53 million J&J vaccines given by the US to Nepal in July.

US donates 100,620 doses of Pfizer vaccines to Nepal

Pfizer’s kid-size Covid vaccine doses are 91 per cent effective against coronavirus and have been observed to be safe. A new study has revealed that the kid-size doses of Pfizer’s vaccine are safe for children aged between 5 and 11.

Pfizer's kid-size doses 91% effective against COVID-19: Study

The US Food and Drug Administration (FDA) has approved a 'mix and match' strategy for all vaccines authorised in the country. The agency said in a statement, "The FDA has determined that the known and potential benefits of the use of a single heterologous booster dose outweigh the known and potential risks of their use in eligible populations.

FDA approves 'mix and match' strategy for all COVID-19 vaccines approved in US

Recently several studies have been claiming that without booster shots, people are bound to get re-infected by coronavirus. However, a new study has claimed two doses of Covishield and Pfizer can guarantee 90 per cent safety from the deadly virus.

Two doses of Covishield and Pfizer vaccine provide 90% safety from Covid: Study

Is Pfizer putting profits above lives? Public Citizen, a non-profit organization says that Pfizer can stop countries from speaking about contracts, block vaccine donations, unilaterally change delivery schedules & demand public assets as collateral. Palki Sharma tells you more.

Gravitas: Revealed: How Pfizer blackmails countries for shots

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news